Company news

Skye Bioscience, Inc. news in 2021

Skye Bioscience, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Skye Bioscience Expands Board of Directors with the Appointment of Life Sciences Executive Keith W. Ward, PhD

December 14, 2021

Skye Bioscience Establishes New Cannabinoid Pharmaceutical Innovation Program

October 11, 2021

Skye Bioscience Appoints Head of Regulatory Affairs & Quality Assurance and Senior Director of Research & Development

October 6, 2021

Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer

October 4, 2021

Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering

September 28, 2021

Skye Bioscience Announces $7.0 Million Registered Direct Offering

September 26, 2021

Skye Bioscience Announces THCVHS Late-Breaking Preclinical Abstracts Selected by American Association of Pharmaceutical Scientists Meeting PharmSci 360

September 20, 2021

Skye Bioscience Announces Special Virtual Investor Presentation

September 13, 2021

Skye Bioscience Completes THCVHS IND-enabling In Vitro Genotoxicity Studies

August 9, 2021

Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to Board of Directors

July 25, 2021

Skye Bioscience Expands Clinical Advisory Board with the Appointment of Ophthalmology Expert Dr. Miguel González-Andrades

June 9, 2021

Skye Bioscience Completes CMC and GLP Production for THCVHS Lead Program

April 21, 2021

Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, MD, PhD to Scientific Advisory Board

March 7, 2021

Decks in 2021